MYGN - MYRIAD GENETICS INC

QQQ $ 446.25 $ -12.35 (-2.68 %)

DIA $ 404.28 $ -3.99 (-0.98 %)

SPY $ 539.90 $ -9.25 (-1.68 %)

TLT $ 99.49 $ -0.01 (-0.01 %)

GLD $ 230.65 $ -1.72 (-0.74 %)

Previous Close

$ 26.97

Open

Bid

$ 26.95 x 300

Ask

$ 26.98 x 100

Day's Range

-- - --

52 Week Range

$ 13.82 - $ 29.08

Volume

547,658

Average Volume

Market Cap

2.45B

Beta (5Y Monthly)

$ 1.47

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2024	06-30-2024	10-Q
2	05-08-2024	03-31-2024	10-Q
3	02-28-2024	12-31-2023	10-K
4	11-07-2023	09-30-2023	10-Q
5	08-04-2023	06-30-2023	10-Q
6	05-04-2023	03-31-2023	10-Q
7	03-01-2023	12-31-2022	10-K
8	11-02-2022	09-30-2022	10-Q
9	08-05-2022	06-30-2022	10-Q
10	05-06-2022	03-31-2022	10-Q
11	02-25-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-04-2021	06-30-2021	10-Q
14	05-05-2021	03-31-2021	10-Q
15	11-09-2020	09-30-2020	10-Q
16	08-13-2020	06-30-2020	10-K
17	05-06-2020	03-31-2020	10-Q
18	02-07-2020	12-31-2019	10-Q
19	11-06-2019	09-30-2019	10-Q
20	08-13-2019	06-30-2019	10-K
21	05-08-2019	03-31-2019	10-Q
22	02-06-2019	12-31-2018	10-Q
23	11-07-2018	09-30-2018	10-Q
24	08-24-2018	06-30-2018	10-K
25	05-09-2018	03-31-2018	10-Q
26	02-07-2018	12-31-2017	10-Q
27	11-08-2017	09-30-2017	10-Q
28	08-09-2017	06-30-2017	10-K
29	05-03-2017	03-31-2017	10-Q
30	02-08-2017	12-31-2016	10-Q
31	11-02-2016	09-30-2016	10-Q
32	08-10-2016	06-30-2016	10-K
33	05-04-2016	03-31-2016	10-Q
34	02-03-2016	12-31-2015	10-Q
35	11-04-2015	09-30-2015	10-Q
36	08-12-2015	06-30-2015	10-K
37	05-06-2015	03-31-2015	10-Q
38	02-04-2015	12-31-2014	10-Q
39	11-05-2014	09-30-2014	10-Q
40	08-13-2014	06-30-2014	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

g-iii-apparel-posts-upbeat-results-joins-nio-yext-shoe-carnival-and-other-big-stocks-moving-higher-on-thursday

G-III Apparel Posts Upbeat Results, Joins ...
09/05/2024 17:44:24

Myriad Genetics Said Due To Significant Di...
09/04/2024 10:20:37

-8-K

Wells Fargo Initiates Coverage On Myriad G...
08/27/2024 22:12:37

Wells Fargo analyst Brandon Couillard initiates coverage on Myriad Genetics (NASDAQ:MYGN) with a Overweight rating and annou...

Scotiabank Maintains Sector Outperform on ...
08/13/2024 15:28:07

Scotiabank analyst Sung Ji Nam maintains Myriad Genetics (NASDAQ:MYGN) with a Sector Outperform and raises the price target ...

Myriad Genetics Stock: A Deep Dive Into An...
08/13/2024 13:01:04

Piper Sandler Maintains Neutral on Myriad ...
08/13/2024 11:19:11

Piper Sandler analyst John Peterson maintains Myriad Genetics (NASDAQ:MYGN) with a Neutral and raises the price target from ...

TD Cowen Maintains Hold on Myriad Genetics...
08/07/2024 21:18:47

TD Cowen analyst Dan Brennan maintains Myriad Genetics (NASDAQ:MYGN) with a Hold and raises the price target from $28 to $30.

JP Morgan Maintains Underweight on Myriad ...
08/07/2024 17:43:06

JP Morgan analyst Rachel Vatnsdal maintains Myriad Genetics (NASDAQ:MYGN) with a Underweight and raises the price target fro...

Myriad Genetics Sees FY24 Gross Revenue $8...
08/06/2024 21:20:16

Myriad Genetics Q2 2024 Adj. EPS $0.05 Bea...
08/06/2024 20:54:37

Myriad Genetics (NASDAQ:MYGN) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.0...

Myriad Genetics And Personalis Announce Cr...
07/11/2024 13:01:05

Myriad Genetics Secures Second Patent To E...
07/09/2024 13:04:21

Key Takeaways From Myriad Genetics Analyst...
06/27/2024 14:00:36

Scotiabank Initiates Coverage On Myriad Ge...
06/27/2024 12:59:25

Scotiabank analyst Sung Ji Nam initiates coverage on Myriad Genetics (NASDAQ:MYGN) with a Sector Outperform rating and annou...

Myriad Genetics Collaborates With GSK To I...
06/11/2024 12:06:59

Myriad Genetics Launches New Universal Plu...
06/04/2024 13:01:10

Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced the addition of a new ...

Myriad Genetics Patient-Outcomes Study Val...
06/03/2024 20:13:52

Jefferies Assumes Myriad Genetics at Under...
06/03/2024 13:11:27

Jefferies analyst Tycho Peterson assumes Myriad Genetics (NASDAQ:MYGN) with a Underperform rating and lowers Price Target of...

QIAGEN And Myriad Genetics To Develop Glob...
05/30/2024 20:30:33

Myriad Genetics Study Published In JCO Pre...
05/16/2024 20:30:28

Myriad's Prolaris Test is the only biomarker test to quantify the benefits of adding androgen deprivation therapy to radiat...